VeriMom¿Es ganoderma lucidum/salix gracilistyla stem ferment extract filtrate seguro durante el embarazo?
No EU Annex II/III listing or harmonised CLP (no H360/H361/H340/H350 found). However, peer‑reviewed in vitro work reports estrogen‑like activity for Ganoderma lucidum extracts, and EWG cites animal studies reporting reproductive/teratogenic effects at high oral doses; this supports a low/theoretical reproductive hazard (h=1) with a theoretical mechanism (in vitro estrogenic activity, m=1) and low but measurable exposure from topical use (e=1). (See cited sources).
Alternativas seguras a ganoderma lucidum/salix gracilistyla stem ferment extract filtrate en el embarazo | VeriMom
Related ingredients
Frequently asked questions
- ¿Es ganoderma lucidum/salix gracilistyla stem ferment extract filtrate seguro durante el embarazo?
- No EU Annex II/III listing or harmonised CLP (no H360/H361/H340/H350 found). However, peer‑reviewed in vitro work reports estrogen‑like activity for Ganoderma lucidum extracts, and EWG cites animal studies reporting reproductive/teratogenic effects at high oral doses; this supports a low/theoretical reproductive hazard (h=1) with a theoretical mechanism (in vitro estrogenic activity, m=1) and low but measurable exposure from topical use (e=1). (See cited sources).
- ¿Es ganoderma lucidum/salix gracilistyla stem ferment extract filtrate seguro durante la lactancia?
- Same rationale as pregnancy: no regulatory bans or harmonised C&L but in vitro estrogenic activity and animal findings raise a theoretical concern. Topical cosmetic use is expected to give low measurable systemic exposure in adults (e=1); no breastfeeding‑specific placental/lactation transfer data were found.
- ¿Es ganoderma lucidum/salix gracilistyla stem ferment extract filtrate seguro para la piel del bebé?
- Hazard and mechanism scores remain low/theoretical (h=1,m=1) — there is no infant‑specific toxicity evidence. Exposure (e) is increased by one point for babies because immature skin has higher absorption; therefore e=2 for 0–3 yr skin when the adult e=1. No data were located showing topical cosmetic formulations cause infant systemic exposure or infant adverse outcomes.
- ¿Cómo puntúa VeriMom a ganoderma lucidum/salix gracilistyla stem ferment extract filtrate?
- VeriMom puntúa ganoderma lucidum/salix gracilistyla stem ferment extract filtrate en 67/100 (riesgo medio) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a ganoderma lucidum/salix gracilistyla stem ferment extract filtrate en el embarazo?
- Consulta nuestra lista de alternativas seguras a ganoderma lucidum/salix gracilistyla stem ferment extract filtrate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.